通过黄胺调节铁化:在胃肠癌中具有治疗潜力
Ruqaia Shoheeduzzaman1, Elizabeth Varghese1, Samson Mathews Samuel1
1Department of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Medbay, Education City, Qatar Foundation, Doha P. O. Box 24144, Qatar.
Journal of advanced research
|July 14, 2025
概括
黄胺在治疗胃肠道癌症方面表现有前途,通过诱导细胞死亡途径铁亡. 本综述探讨了它们作为抗癌剂和敏感剂的潜力,以改善当前的治疗方法.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 早期发病的胃肠道癌症的发病率上升.
- 癌细胞对亡的抗性构成了治疗挑战.
- 铁,一种依赖于铁的细胞死亡,成为一个有希望的替代方案.
研究的目的:
- 审查关于黄类药物在胃肠道癌症中诱导铁亡的临床前证据.
- 描述铁灭的机制和合成调节器.
- 介绍黄类,它们的分类,结构和抗癌活性.
主要方法:
- 临床前研究的文献综述.
- 对黄类的分类,化学结构和抗癌作用的分析.
- 检查由黄素向的铁亡途径.
主要成果:
- 黄类药物向关键的铁亡途径,包括GPX4,Xc系统,脂质和铁代谢.
- 黄类药物显示出潜力作为癌细胞中铁亡的诱导剂.
- 黄类药物具有抗癌活性,可以使细胞对现有治疗方法敏感.
结论:
- 黄类药物诱导的铁死为胃肠癌提供了一种新的治疗策略.
- 黄类药物可以作为直接的抗癌剂和敏感剂.
- 需要进一步的研究来应对挑战并探索未来的范围.
更多相关视频
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


